Application of proprotein convertase subtilisin/kexin type 9 inhibitor, evolocumab, in patients with severe hypertriglyceridemia

相关推荐

• The difference of immunologic parameters between SARS patients of mild type and severe type
• Application of damage control orthopedics in 41 patients with severe multiple injuries
• Application of trauma time axis management in the treatment of severe trauma patients
• Application of ulinastatin in severe craniocerebral injuries
• First aid strategy for severe traumatic patients in hospital

同分类资源 更多

• [医药卫生] 肺血管功能障碍与急性肺损伤患者预后的关系研究
• [医药卫生] 早期上皮性卵巢癌化学治疗现状与思考
• [医药卫生] 正确选择喉癌治疗方式、提高患者的生存率及生活质量
• [医药卫生] 贝叶斯网状Meta分析预测头孢菌素类抗菌药物联合甲硝唑治疗腹腔感染的疗效和安全性
• [医药卫生] 微小RNA-29a-5p通过Endoglin改善心肌梗死后心肌纤维化

相关关键词